What Price Target Has Jefferies Given Aurora Cannabis (TSE:ACB)

The financial firm Jefferies began coverage of ACB’s shares on 25 February. Jefferies’s Stock research analysts have issued Buy rating while giving it the target at $12.

Ticker’s shares touched $10.06 during the last trading session after 4.90% change.Aurora Cannabis Inc. has volume of 13.24 million shares. Since February 26, 2018 ACB has 0.00% and is . ACB by 0.00% the S&P500.

Aurora Cannabis Inc. produces and distributes medical cannabis products.The company has $10.05 billion market cap. It is vertically integrated and horizontally diversified across various divisions of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.Last it reported negative earnings. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products.

For more Aurora Cannabis Inc. (TSE:ACB) news brought out briefly go to: Midasletter.com, Warriortradingnews.com, Midasletter.com, Forbes.com or Midasletter.com. The titles are as follows: “Canaccord Genuity Inc (TSE:CF) Analyst on Aurora Cannabis (TSE:ACB) and Canopy Growth (TSE:WEED) Financials – Midas Letter” brought out on February 22, 2019, “Canadian Cannabis Producer Flowr Corporation to List on NASDAQ – Warrior Trading News” on February 06, 2019, “Analyst Dmitry Zaytsev Discusses Bearish Outlook on Upcoming Financials – Midas Letter” with a publish date: February 08, 2019, “What’s Ahead For Aurora Cannabis After An Impressive FY 2018 – Forbes” and the last “Canopy Growth Corp (TSE:WEED), Aurora Cannabis Inc (TSE:ACB) Lead Sector Lower – Midas Letter” with publication date: April 02, 2018.